Page last updated: 2024-09-03

sr 11237 and liarozole

sr 11237 has been researched along with liarozole in 1 studies

Compound Research Comparison

Studies
(sr 11237)
Trials
(sr 11237)
Recent Studies (post-2010)
(sr 11237)
Studies
(liarozole)
Trials
(liarozole)
Recent Studies (post-2010) (liarozole)
26091012314

Protein Interaction Comparison

ProteinTaxonomysr 11237 (IC50)liarozole (IC50)
Cytochrome P450 26A1Homo sapiens (human)3.29
Cytochrome P450 1A2Homo sapiens (human)0.54
Cytochrome P450 3A4Homo sapiens (human)0.354
Cytochrome P450 2D6Homo sapiens (human)4.76
AromataseHomo sapiens (human)0.0248
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialHomo sapiens (human)0.0023
Cytochrome P450 26B1Homo sapiens (human)0.018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Astruc-Diaz, F; Buttrick, B; Diaz, P; Fronczek, FR; Guilloteau, N; Huang, W; Isoherranen, N; Keyari, CM; Price, L; Sperandio, VG; Tripathy, S1

Other Studies

1 other study(ies) available for sr 11237 and liarozole

ArticleYear
Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.
    Journal of medicinal chemistry, 2016, Mar-24, Volume: 59, Issue:6

    Topics: Algorithms; Animals; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Drug Design; Drug Resistance; Enzyme Induction; Enzyme Inhibitors; Humans; Isoenzymes; Kinetics; Liver; Rats; Retinoic Acid 4-Hydroxylase; Structure-Activity Relationship; Substrate Specificity; Tretinoin

2016